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LC–MS data from maternal plasma of 180 healthy
pregnant women
Hemi Luan1,2, Nan Meng2, Ping Liu2, Jin Fu2, Xiaomin Chen2, Weiqiao Rao2, Hui Jiang2, Xun Xu2,
Zongwei Cai1* and Jun Wang2,3*Abstract
Background: Metabolomics has the potential to be a powerful and sensitive approach for investigating the low
molecular weight metabolite profiles present in maternal fluids and their role in pregnancy.
Findings: In this Data Note, LC–MS metabolome, lipidome and carnitine profiling data were collected from 180
healthy pregnant women, representing six time points spanning all three trimesters, and providing sufficient
coverage to model the progression of normal pregnancy.
Conclusions: As a relatively large scale, real-world dataset with robust numbers of quality control samples, the data
are expected to prove useful for algorithm optimization and development, with the potential to augment studies into
abnormal pregnancy. All data and ISA-TAB format enriched metadata are available for download in the MetaboLights
and GigaScience databases.
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Purpose of collection
Metabolic variations occur during normal pregnancy to
provide the developing foetus with a supply of nutrients
required for development, and to ensure the health of
the mother during gestation. The following dataset was
collected to study metabolic phenotype variations in the
maternal plasma, which are induced by pregnancy dur-
ing each of its three trimesters [1]. All work described
here is associated with this report, which used liquid
chromatography–mass spectrometry (LC–MS) to survey
the effects of pregnancy on the metabolite profiles of
maternal plasma during pregnancy. A basic overview of
the three datasets for the different experiments is shown
in Figure 1. Full details of the batch numbers, run order
and distribution of QCs can be seen in Additional file 1.* Correspondence: zwcai@hkbu.edu.hk; wangj@genomics.cn
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A total of 180 healthy pregnant women were recrui-
ted from the Maternity and Child Health Hospital of
Shenzhen, China. Full ethical approval for this study
was provided by the Institutional Review Board of BGI-
Shenzhen (No. 13045). All volunteers gave written in-
formed consent and filled out an individual questionnaire
at the time of collection for the study. Clinical informa-
tion was obtained from neonatal and obstetrical medical
records. Pregnancy was followed up to term to ensure
participating women had normal term pregnancies and
healthy babies. Individual participants were divided into
six subgroups of 30 individuals according to their gesta-
tional weeks: class A (9w ~ 12w), class B (13w ~ 16w),
class C (17w ~ 20w), class D (21w ~ 24w), class E (25w ~
28w), and class F (29w ~ 40w). Weight, height, age and
gestational week were recorded. Venous blood was col-
lected in the morning before breakfast using VACU-
ETTE® EDTA Blood Collection Tubes (Greiner Bio-One
GmbH, NC, USA). Plasma samples were separated at
2200 g for 5 min at 4°C from vein blood and stored athis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 An overview of the three datasets for the different experiments.
Luan et al. GigaScience  (2015) 4:16 Page 2 of 4−80°C until use. One sample was collected per patient,
rather than multiple collections for each subject.
Non-targeted metabolic profiling spectral acquisition
Low molecular weight metabolites (<1000 Da) in the
plasma samples were isolated using methanol precipita-
tion with slight modifications to previously reported pro-
tocols [1,2]. To outline these briefly, 50 μl of thawed
plasma was collected and precipitated using 200 μl of
methanol. After centrifugation at 14000 g for 10 min at
4°C, the supernatant was transferred to 1.5 mL polypro-
pylene tubes, and 10 μL of the supernatant injected into
the LC–MS equipment. Quality control (QC) samples
were also prepared by mixing equal volumes (10 μL)
from each plasma sample before sample preparation as
they were being aliquoted for analysis. This pooled sample
was then used to estimate a mean profile representing all
the analytes encountered during the analysis [3-4].
LC–MS data was acquired using a Shimadzu Promin-
ence HPLC system (Shimadzu, Japan), coupled online to
a LTQ Orbitrap Velos instrument (Thermo Fisher Scien-
tific, MA, USA) set at a resolution of 30,000 (at m/z
400). Sample analysis was carried out in both positive
and negative ion modes with the mass scanning range at
50–1500m/z and capillary temperature of 350°C. Nitro-
gen sheath gas was set at a flow rate of 30 L/min, and
auxiliary gas was set at a flow rate of 10 L/min. Spray
voltage was 4.5 kV, with the LC–MS system run in bin-
ary gradient mode. Solvent A was 0.1% (v/v) formic
acid/water and solvent B was 0.1% (v/v) formic acid/
methanol; the flow rate was 0.2 ml/min. A C-18 column
(150 × 2.1 mm, 3.5 μm, Agilent, USA) was used for all
analysis. The following gradient was used: 5% B at
0 min, 5% B at 5 min, 100% B at 8 min, 100% B at
9 min, 5% B at 18 min and 5% B at 20 min.
The positive ion dataset was run as two batches, with
the pooled QC sample repeated once every sixth sample.
This produced final spectra as follows: 30 class A; 28class B; 30 class C; 30 class D; 30 class E; 30 class F; and
39 QC samples spread throughout. The negative ion
dataset was run as five batches, with the pooled QC
sample injected five times at the start of the run, three
times at the end, and once every five samples. The nega-
tive ion data has final spectral numbers of: 28 class A;
26 class B; 27 class C; 29 class D; 26 class E; 25 class F;
and 66 QC samples spread throughout. Additionally,
three blank samples were injected before the starting
QC of each run for baseline stabilisation of the LC–MS
system – these blank spectra are not included in these
published data. Discrepancies with sample numbers are
due to some samples being used up entirely as repeats
were performed to correct for failed spectra. The posi-
tive and negative ion mode LC–MS data were collected
in two batches and five batches, respectively, due to an
observation that the negative ion responses decreased
faster than positive ion responses.
Shotgun lipidomics and carnitine profiling spectral
acquisition
Lipidomics analysis was carried out as previously described,
with slight modifications to previously reported protocols
[5,6]. Plasma samples were thawed and extracted, with
10 μL of plasma placed in 1 mL glass vials. Eight μL of an
internal standards mixture consisting of ceramide (Cer,
d18:1/17:0), phosphoethanolamine (PE, 17:0), phosphati-
dylserine (PS, 17:0), l-α-phosphatidylinositol (Soy PI),
phosphatidylcholine (PC, 18:3), and phosphoglycerol (PG,
17:0), with a concentration of 10 μM for each lipid, was
added. Individual lipids were purchased from Avanti Polar
Lipids (Alabaster, AL). Following this, 800 μL of chloro-
form/methanol/water (20:10:1, V/V/V) containing 300 mM
ammonium acetate was added and vortexed. After 10 min,
centrifugation at 14000 g and 10°C (Eppendorf, Hamburg,
Germany) was performed and 100 μL of the lower or-
ganic layer was diluted with 100 μL of methanol/chloro-
form (2:1, V/V) containing 10 mM ammonium acetate.
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Lipidome and carnitine profiling were detected by
multiplexed precursor ion scanning (MPIS) analysis.
One hundred μL of final extract was loaded into 96 well
plates (Eppendorf, Hamburg, Germany) and sealed with
aluminium foil. The final extracts were analysed using a
QTRAP® 5500 System equipped with a Shimadzu Prom-
inence HPLC system (Shimadzu, Japan). Liquid chroma-
tography and flow injection analysis–mass spectrometry
were employed to acquire the data. The electrospray
source was operated in the positive ion mode, with
optimised source parameters: ionSpray Voltage 5.5 kV,
source temperature 300°C, curtain gas 30. Collision en-
ergies ranged from 25–30 V for various lipid species in
precursor ion or neutral loss scan modes. Flow injection
analysis was performed with a mixture of chloroform-
methanol-10 mM ammonium acetate in water (300/665/
35, V/V/V) at a flow rate of 200 μl/min. Total analysis
time per sample was 3.6 min. PE, PC, PS, PI, PG, Cer
and carnitines were monitored by consecutive positive
ion mode PIS m/z 141.0, 184.1, 185.0, 277.0, 189.0, 264.2
and 85.1, respectively. Acquired spectra were processed
by LipidView™ and ChemoView™ software (AB Sciex) for
isotope correction, identification and quantification of
detected lipid and carnitine species as previously de-
scribed [5-7].
This lipidomics dataset was run as two batches, with
the pooled QC sample injected three times at the start,
three times at the end and once every 20 samples. This
dataset comprises: 29 class A; 29 class B; 30 class C; 30
class D; 30 class E; 29 class F; 14 QC samples throughout.Potential uses
On top of the already published work characterising
metabolic phenotype variations during pregnancy, these
data also provide a useful baseline and reference dataset
to be compared to specific conditions (e.g. hypertensive
disorders, diabetes mellitus) in pregnancy. The data were
observed to be of good quality via plotting (PCA scores)
of QCs alongside samples and noting that the QC
samples were tightly clustered. This was observed after
processing, full details of which can be found in the pre-
viously published research article [1]. Although the po-
sitive ion, non-targeted dataset was not randomised
during LC–MS collection, the inclusion of QC samples
throughout the collection process arguably allows for
correction of drift and other systematic noise (e.g.
biases correlated with analysis order and/or sample
preparation order). The other two datasets were fully
pseudo-randomised. The large scale of this dataset
and the inclusion of quality control measures makes it
very useful for algorithm optimisation and development,especially those that deal with quality control issues such
as batch and drift correction [8-9].
The lipidomics and carnitine dataset ought to be of
particular use as a biological reference when studying
abnormal pregnancy due to its ability to describe nutri-
tion and energy levels in the subject.
Availability of supporting data and materials
Supporting data and corresponding ISA-TAB metadata
are available in the MetaboLights database [MTBLS146],
as well as the GigaScience GigaDB repository [10].
Additional file
Additional file 1: A detailed, graphical depiction of batch numbers,
run order and distribution of QCs for all datasets.
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